Alembic Ltd.

Financial

	Alembic	Kolte-Patil Develop.	Marathon NextgenReal
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	10.3 %	n/a	n/a
R&D as a % of Total Sales	0.06 %	n/a	n/a
Financials
5 yr Average ROE	13.7 %	3.64 %	8.92 %
5yr average Equity Multiplier	1.05	4.6	2.76
5yr Average Asset Turnover Ratio	0.05	0.29	0.21
5yr Avg Net Profit Margin	303.17 %	2.93 %	14.1 %
Price to Book	1.14	3.56	2.32
P/E	8.15	180.64	14.55
5yr Avg Cash Conversion Cycle	79.64 Days	696.99 Days	281.42 Days
Inventory Days	237.67 Days	970.87 Days	573.67 Days
Days Receivable	50.07 Days	11.04 Days	35.67 Days
Days Payable	292.14 Days	151.0 Days	181.55 Days
5yr Average Interest Coverage Ratio	181.25	2.69	2.02
5yr Avg ROCE	4.08 %	12.99 %	10.41 %
5yr Avg Operating Profit Margin	20.81 %	12.22 %	29.69 %
5 yr average Debt to Equity	0.0	0.84	1.14
5yr CAGR Net Profit	-3.98 %	n/a	47.21 %
5yr Average Return on Assets	13.04 %	1.04 %	3.45 %
Shareholdings
Promoter Holding	70.88 %	69.45 %	73.63 %
Share Pledged by Promoters	0.0	0.0	91.46 %
Change in Promoter Holding (3 Yrs)	0.0	-5.0 %	-1.34 %
Change in Mutual Fund Holding (3 Yrs)	-4.63 %	0.8 %	2.42 %

Business

	Alembic	Kolte-Patil Develop.	Marathon NextgenReal
Product Wise Break-Up	Product Wise Break-Up Real Estate 89.21 Active Pharmaceutical Ingredient (API) 10.79 Residential/Commercial 0 Commercial 0	Product Wise Break-Up Real Estate 0 Residential/Commercial 89.75 Commercial 0 Active Pharmaceutical Ingredient (API) 0 Others 10.25	Product Wise Break-Up Real Estate 100.0 Residential/Commercial 0 Commercial 0 Active Pharmaceutical Ingredient (API) 0
Location Wise Break-Up	Location Wise Break-Up India 95.48 Rest of the World 2.4 Others 2.12	Location Wise Break-Up India 100.0 Rest of the World 0	Location Wise Break-Up India 100.0 Rest of the World 0
Operating Profit Break-Up	Operating Profit Break-Up Real Estate 92.72 API 7.28	-	-
Asset Break-Up	Asset Break-Up Others 100	-	-